Advanced search
Publication Cover
Autoimmunity Volume 40, 2007 - Issue 1
Submit an article Journal homepage
113
Views
15
CrossRef citations to date
0
Altmetric
Original

Gene expression profiles reveal homeostatic dynamics during interferon-β therapy in multiple sclerosis

Viviana Annibali Department of Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
,
Simone Di Giovanni Department of Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
,
Stefania Cannoni Department of Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
,
Elisabetta Giugni Neuroradiology, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
,
Roberto Bomprezzi Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD20892, USA
,
Carlo Mattei Department of Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
,
Abdel Elkahloun Cancer Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD20892, USA
,
Eliana Marina Coccia Department of Infectious, Parasitic and Immune-Mediated Diseases, Istituto Superiore di Sanità, Rome, Italy
,
Marco Alfò Department of Statistics, Probability and Applied Statistics, University of Rome “La Sapienza”, Rome, Italy
,
Francesco Orzi Department of Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
,
Giovanni Ristori Department of Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
&
Marco Salvetti Department of Neurology and Center for Experimental Neurological Therapy, S. Andrea Hospital, University of Rome “La Sapienza”, Rome, Italy
 show all
Pages 16-22 | Received 20 Sep 2006, Accepted 22 Nov 2006, Published online: 07 Jul 2009

References

  • Goodin DS, Frohman EM, Garmany GP, Jr., et al. Disease modifying therapies in multiple sclerosis: Report of the Therapeutics And Technology Assessment Subcommittee of The American Academy Of Neurology and the MS Council For Clinical Practice Guidelines. Neurology 2002; 58: 169–178
  • Koike F, Satoh J, Miyake S, et al. Microarray analysis identifies interferon beta-regulated genes in multiple sclerosis. J Neuroimmunol 2003; 139: 109–118
  • Weinstock-Guttman B, Badgett D, Patrick K, et al. Genomic effects of IFN-beta in multiple sclerosis patients. J Immunol 2003; 171: 2694–2702
  • Yang, IV, Chen E, Hasseman JP, et al. Within the fold: Assessing differential expression measures and reproducibility in microarray assays. Genome Biol 2002; 3, research0062
  • Sturzebecher S, Wandinger KP, Rosenwald A, et al. Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. Brain 2003; 126: 1419–1429
  • Byskosh PV, Reder AT. Interferon beta-1b effects on cytokine mRNA in peripheral mononuclear cells in multiple sclerosis. Mult Scler 1996; 1: 262–269
  • Byrnes AA, McArthur JC, Karp CL. Interferon-beta therapy for multiple sclerosis induces reciprocal changes in interleukin-12 and interleukin-10 production. Ann Neurol 2002; 51: 165–174
  • Bertram EM, Hawley RG, Watts TH. Overexpression of rab7 enhances the kinetics of antigen processing and presentation with MHC class II molecules in B cells. Int Immunol 2002; 14: 309–318
  • Skundric DS, Dai R, Zakarian VL, et al. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE. J Neurosci Res 2005; 79: 680–693
  • Wandinger KP, Sturzebecher CS, Bielekova B, et al. Complex immunomodulatory effects of interferon-beta in multiple sclerosis include the upregulation of T helper 1-associated marker genes. Ann Neurol 2001; 50: 349–357
  • Fainardi E, Rizzo R, Melchiorri L, et al. Beneficial effect of interferon-beta 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy. J Neuroimmunol 2004; 148: 206–211
  • Negro F, Baldi M, Mondardini A, et al. Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2a. Gastroenterology 1994; 107: 479–485

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.